Learn more

GENMONT BIOTECH INC

Overview
  • Total Patents
    134
  • GoodIP Patent Rank
    23,106
  • Filing trend
    ⇧ 100.0%
About

GENMONT BIOTECH INC has a total of 134 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in Taiwan, United States and China. Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are CELL BIOTECH CO LTD, COENBIO CO LTD and GRAPE KING BIO LTD.

Patent filings in countries

World map showing GENMONT BIOTECH INCs patent filings in countries

Patent filings per year

Chart showing GENMONT BIOTECH INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chen Yi-Hsing 33
#2 Tsai Wan-Hua 24
#3 Hsu Ching-Hsiang 21
#4 Hsieh Feng-Ching 20
#5 Su Wei-Chih 15
#6 Chen Yi Hsing 13
#7 Chen Yixing 12
#8 Chou Chia-Hsuan 11
#9 Lu Ying-Chen 11
#10 Huang Tsuei-Yin 9

Latest patents

Publication Filing date Title
US2020054694A1 Topical composition, pharmaceutical composition containing inactivated culture and method of facilitating wound healing and scar reduction using the same
US10639336B1 Use of a probiotic composition for preventing stroke and ameliorating the severity of stroke
CN112007051A Composition for preventing apoplexy and improving apoplexy severity and application thereof
TWI698187B Composition for preventing stroke and improving the severity of stroke and use thereof including an effective amount of Lactobacillus reuteri GMNL-89 and Lactobacillus paracasei GMNL-133
US2019381118A1 Use of Lactobacillus paracasei GMNL-653 for preparing for a composition for alleviating axillary osmidrosis
US2020077692A1 Lactobacillus composition for inhibiting gastritis induced by gastric helicobacter pylori and use thereof
TW202008997A Topical composition, medicinal composition containing inactivated culture and use thereof for facilitating wound healing and scar reduction
TW202007401A Lactic acid bacteria composition used to inhibit gastritis caused by Helicobacter pylori, H. pylori and use thereof characterized by achieving the effect of inhibiting multi-drug resistant Helicobacter pylori and antibiotic sensitive Helicobacter pylori
TW202005662A Use of Lactobacillus paracasei strain GMNL-653 for preparing medicinal composition for improving body odor
US2019388484A1 Lactobacillus reuteri gmnl-263 for improving hypertension and its compositions thereof
US10456430B1 Lactobacillus composition for prevention and treatment of bacterial vaginosis
TWI667344B Bacterial strain of Lactobacillus reuteri GMNL-263 capable of improving hypertension and composition thereof for lowering blood pressure by inhibiting pro-inflammatory cytokines IL-1<beta> and improving growth of Bifidobacterium
CN110384719A The L. reuteri strain GMNL-263 and combinations thereof of hypertension can be improved
TWI666316B Lactic acid bacteria composition capable of preventing and treating bacterial vaginitis by inhibiting the growth of pathogenic bacteria and regulating the expression of immunoregulatory factors
CN110339216A It can prevent and treat the lactic bacteria composition of bacterial vaginitis
TW202002791A Plant growth regulator of elevating anti-stress ability and use thereof
CN108450482A Improve the plant growth regulator and application thereof of degeneration-resistant border ability
CN108707557A Prevent, improve or slow down probiotic composition and its application of cancer of pancreas
TW201940183A Probiotic composition for preventing, improving or alleviating pancreatic cancer and application thereof
US2019247295A1 Use of lactobacillus plantarum gmnl-6 composition for skin care